| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
24,270,000 |
| Market
Cap: |
527.87(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$20.03 - $40.81 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fulgent Genetics is a holding company. Through its subsidiaries, Co. is a technology company providing COVID-19 testing services, molecular diagnostic testing services and genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Co. has developed a proprietary technology platform allowing Co. to provide a test menu. Combining next generation sequencing with its technology platform, Co. performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet customer needs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
29,577 |
54,115 |
78,957 |
| Total Sell Value |
$0 |
$791,434 |
$1,639,451 |
$2,902,369 |
| Total People Sold |
0 |
3 |
3 |
4 |
| Total Sell Transactions |
0 |
6 |
19 |
36 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gao Hanlin |
Chief Scientific Officer |
• – – |
2020-09-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(467,659) |
813,692 |
|
- |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2020-09-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(150,000) |
451,736 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-09-02 |
4 |
S |
$28.32 |
$12,035 |
D/D |
(425) |
335,899 |
|
-140% |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2020-08-28 |
4 |
S |
$30.82 |
$13,591 |
D/D |
(441) |
601,295 |
|
-105% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-08-19 |
4 |
AS |
$44.16 |
$1,122,039 |
D/D |
(25,407) |
335,774 |
|
18% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-08-17 |
4 |
AS |
$41.11 |
$4,633,097 |
D/D |
(111,236) |
361,181 |
|
17% |
|
| Gao Hanlin |
Chief Scientific Officer |
• – – |
2020-08-17 |
4 |
S |
$41.11 |
$53,772 |
D/D |
(1,308) |
1,281,351 |
|
-17% |
|
| Bolger John C |
Director |
– • – |
2020-08-17 |
4 |
S |
$40.87 |
$159,967 |
D/D |
(3,914) |
2,013 |
|
-17% |
|
| Bolger John C |
Director |
– • – |
2020-08-17 |
4 |
OE |
$12.31 |
$32,393 |
D/D |
2,631 |
5,927 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-08-11 |
4 |
S |
$42.06 |
$58,712 |
D/D |
(1,396) |
472,417 |
|
-22% |
|
| Xie Jian |
Chief Operating OfficerOfficer |
• – – |
2020-08-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
403,712 |
|
58% |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2020-08-03 |
4 |
S |
$27.86 |
$55,055 |
D/D |
(1,976) |
601,736 |
|
-58% |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
603,712 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
473,813 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-06-02 |
4 |
S |
$18.06 |
$7,674 |
D/D |
(425) |
433,813 |
|
-129% |
|
| Yen Yun |
Director |
– • – |
2020-05-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(526,315) |
0 |
|
- |
|
| Bolger John C |
Director |
– • – |
2020-05-22 |
4 |
S |
$15.36 |
$133,288 |
D/D |
(8,677) |
3,296 |
|
-202% |
|
| Bolger John C |
Director |
– • – |
2020-05-22 |
4 |
OE |
$0.38 |
$10,812 |
D/D |
5,131 |
11,973 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-05-12 |
4 |
S |
$16.31 |
$23,176 |
D/D |
(1,421) |
434,238 |
|
-140% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-03-01 |
4 |
D |
$14.84 |
$23,922 |
D/D |
(1,612) |
435,659 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-02-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,300 |
437,271 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2020-02-10 |
4 |
D |
$16.84 |
$22,313 |
D/D |
(1,325) |
438,571 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2019-11-11 |
4 |
D |
$15.82 |
$20,977 |
D/D |
(1,326) |
439,896 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2019-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
441,222 |
|
- |
|
| Gao Hanlin |
Chief Scientific Officer |
• – • |
2019-09-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(500,000) |
1,267,659 |
|
- |
|
277 Records found
|
|
Page 9 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.04 (0.18%) 
